These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16316744)

  • 41. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
    Elger C; Bialer M; Cramer JA; Maia J; Almeida L; Soares-da-Silva P
    Epilepsia; 2007 Mar; 48(3):497-504. PubMed ID: 17319919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures.
    Faught E
    Seizure; 2004 Dec; 13 Suppl 1():S59-65; discussion S71-2. PubMed ID: 15511695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zonisamide for drug-resistant partial epilepsy.
    Chadwick DW; Marson AG
    Cochrane Database Syst Rev; 2000; (2):CD001416. PubMed ID: 10796786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients.
    Heo K; Lee BI; Yi SD; Cho YW; Shin DJ; Song HK; Kim OJ; Park SP; Kim SE; Kim SH; Lee JH; Kim KS; Lee SJ
    Seizure; 2012 Apr; 21(3):188-93. PubMed ID: 22226572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
    Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zonisamide: a review of its use in the management of adults with partial seizures.
    Hoy SM
    Drugs; 2013 Aug; 73(12):1321-38. PubMed ID: 23873520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zonisamide: physician and patient experiences.
    Marmarou A; Pellock JM
    Epilepsy Res; 2005; 64(1-2):63-9. PubMed ID: 15869867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
    Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zonisamide: a review of its use as adjunctive therapy in the management of partial seizures in pediatric patients aged ≥6 years.
    Hoy SM
    Paediatr Drugs; 2014 Jun; 16(3):235-46. PubMed ID: 24668240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures.
    Niklson I; Edrich P; Verdru P
    Epileptic Disord; 2006 Mar; 8(1):37-44. PubMed ID: 16567324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of adjunctive zonisamide in adult patients with refractory partial-onset epilepsy: a randomized, double-blind, placebo-controlled trial.
    Lu Y; Xiao Z; Yu W; Xiao F; Xiao Z; Hu Y; Chen Y; Wang X
    Clin Drug Investig; 2011; 31(4):221-9. PubMed ID: 21166480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.
    Porter RJ; Burdette DE; Gil-Nagel A; Hall ST; White R; Shaikh S; DeRossett SE
    Epilepsy Res; 2012 Aug; 101(1-2):103-12. PubMed ID: 22512894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential efficacy of zonisamide in refractory juvenile myoclonic epilepsy: retrospective evidence from an Irish compassionate-use case series.
    O'Rourke D; Flynn C; White M; Doherty C; Delanty N
    Ir Med J; 2007 Apr; 100(4):431-3. PubMed ID: 17566478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zonisamide: a review of its use in the management of partial seizures in epilepsy.
    Frampton JE; Scott LJ
    CNS Drugs; 2005; 19(4):347-67. PubMed ID: 15813651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A long-term follow-up of zonisamide monotherapy.
    Fukushima K; Seino M
    Epilepsia; 2006 Nov; 47(11):1860-4. PubMed ID: 17116025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and tolerability of zonisamide in paediatric patients with epilepsy.
    Cross JH; Auvin S; Patten A; Giorgi L
    Eur J Paediatr Neurol; 2014 Nov; 18(6):747-58. PubMed ID: 25128350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zonisamide: newer antiepileptic agent with multiple mechanisms of action.
    Biton V
    Expert Rev Neurother; 2004 Nov; 4(6):935-43. PubMed ID: 15853520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zonisamide add-on for drug-resistant partial epilepsy.
    Chadwick DW; Marson AG
    Cochrane Database Syst Rev; 2002; (2):CD001416. PubMed ID: 12076409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.